Scientific Resources

Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.

Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.

December 13, 2021 | Abstract
Concurrent Pembrolizumab with AVD for Untreated Classical Hodgkin Lymphoma
ASH
Read More
December 13, 2021 | Abstract
Profiling of Circulating Tumor DNA for Noninvasive Disease Detection, Risk Stratification, and MRD Monitoring in Patients with CNS Lymphoma
ASH
Read More
December 13, 2021 | Abstract
Phase 2 Study of Acalabrutinib Window Prior to Frontline Therapy in Untreated Aggressive B-Cell Lymphoma: Preliminary Results and Correlatives of Response to Acalabrutinib
ASH
Read More
June 3, 2021 | Poster
Phased variants improve DLBCL minimal residual disease detection at the end of therapy
ASCO
Read More
June 3, 2021 | Poster
Leveraging Phased Variants for Personalized Minimal Residual Disease Detection in Localized Non-Small Cell Lung Cancer
ASCO
Read More
March 25, 2020 | Manuscript
Integrating genomic features for non-invasive early lung cancer detection
Nature
Read More